Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel Free OCEAW Stock Alerts

Ocean Biomedical (OCEAW) Competitors

Compare

OCEAW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Ocean Biomedical stock or one of its competitors? MarketBeat compares Ocean Biomedical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ocean Biomedical include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Ocean Biomedical compare to Ainos?

Ocean Biomedical (NASDAQ:OCEAW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

In the previous week, Ainos had 2 more articles in the media than Ocean Biomedical. MarketBeat recorded 2 mentions for Ainos and 0 mentions for Ocean Biomedical. Ainos' average media sentiment score of 0.44 beat Ocean Biomedical's score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company Overall Sentiment
Ocean Biomedical Neutral
Ainos Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Ainos N/A N/A N/A

Summary

Ainos beats Ocean Biomedical on 3 of the 3 factors compared between the two stocks.

How does Ocean Biomedical compare to Alvotech?

Ocean Biomedical (NASDAQ:OCEAW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends.

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Alvotech had 2 more articles in the media than Ocean Biomedical. MarketBeat recorded 2 mentions for Alvotech and 0 mentions for Ocean Biomedical. Alvotech's average media sentiment score of 1.44 beat Ocean Biomedical's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company Overall Sentiment
Ocean Biomedical Neutral
Alvotech Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

Summary

Alvotech beats Ocean Biomedical on 3 of the 3 factors compared between the two stocks.

How does Ocean Biomedical compare to Aravive?

Aravive (NASDAQ:ARAV) and Ocean Biomedical (NASDAQ:OCEAW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership, media sentiment and dividends.

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Aravive's average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
Ocean Biomedical Neutral

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Ocean Biomedical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Ocean BiomedicalN/AN/AN/AN/AN/A

Summary

Aravive beats Ocean Biomedical on 2 of the 2 factors compared between the two stocks.

How does Ocean Biomedical compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Ocean Biomedical (NASDAQ:OCEAW) are both pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Ocean Biomedical Neutral

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Ocean Biomedical N/A N/A N/A

Summary

Atlantic Coastal Acquisition Corp. II and Ocean Biomedical tied by winning 0 of the 0 factors compared between the two stocks.

How does Ocean Biomedical compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Ocean Biomedical (NASDAQ:OCEAW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

In the previous week, Biofrontera had 2 more articles in the media than Ocean Biomedical. MarketBeat recorded 2 mentions for Biofrontera and 0 mentions for Ocean Biomedical. Biofrontera's average media sentiment score of 0.43 beat Ocean Biomedical's score of 0.00 indicating that Biofrontera is being referred to more favorably in the media.

Company Overall Sentiment
Biofrontera Neutral
Ocean Biomedical Neutral

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Ocean Biomedical N/A N/A N/A

Summary

Biofrontera beats Ocean Biomedical on 3 of the 3 factors compared between the two stocks.

Get Ocean Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCEAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OCEAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OCEAW vs. The Competition

Export
MetricOcean BiomedicalBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$388.04M$55.95B$30.05B
Dividend YieldN/A3.86%2.69%5.33%
P/E RatioN/A3.0721.6326.27
Price / SalesN/A7,203.00565.57116.86
Price / CashN/A13.1343.2256.84
Price / BookN/A85.4810.557.30
Net IncomeN/A-$96.07M$3.56B$337.27M

Ocean Biomedical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCEAW
Ocean Biomedical
N/AN/AN/AN/A$0.00N/AN/A2
AIMDW
Ainos
N/A$0.13
+116.7%		N/A-21.5%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.18
-5.1%		N/A-88.0%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OCEAW) was last updated on 5/31/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel